Northwest Biotherapeutics Stock Forecast

Sell candidate since Jun 02, 2026 Loss -0.98%

The Northwest Biotherapeutics stock price fell by -0.98% on the last day (Friday, 5th Jun 2026) from $0.205 to $0.203. During the last trading day the stock fluctuated 3.69% from a day low at $0.198 to a day high of $0.205. The price has been going up and down for this period, and there has been a -12.65% loss for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -734 thousand shares and in total, 0 shares were bought and sold for approximately $0 .

The stock lies in the lower part of a very wide and weak rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.189 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 6.44% during the next 3 months and, with a 90% probability hold a price between $0.201 and $0.285 at the end of this 3-month period.

NWBO Signals & Forecast

There are few to no technical positive signals at the moment. The Northwest Biotherapeutics stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.212 and $0.219. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, May 29, 2026, and so far it has fallen -11.35%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Northwest Biotherapeutics stock

Northwest Biotherapeutics finds support from accumulated volume at $0.200 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0.0073 between high and low, or 3.69%. For the last week the stock has had daily average volatility of 8.59%

Northwest Biotherapeutics is oversold on RSI14 (24). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (NWBO) For The Upcoming Trading Day Of Monday 8th

For the upcoming trading day on Monday, 8th we expect Northwest Biotherapeutics to open at $0.202, and during the day (based on 14 day Average True Range), to move between $0.194 and $0.212, which gives a possible trading interval of +/-$0.0190 (+/-9.81%) up or down from last closing price. If Northwest Biotherapeutics takes out the full calculated possible swing range there will be an estimated 9.81% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.205 (0.99%) than the support at $0.200 (1.48%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Northwest Biotherapeutics stock A Buy?

The Northwest Biotherapeutics stock holds several negative signals and despite the positive trend, we believe Northwest Biotherapeutics will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -1.456 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 8, 2026 - $0.202 ( 0.509%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk